NCT07086391View on ClinicalTrials.gov

Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.

RecruitingOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

July 1, 2025

Study Completion Date

February 1, 2026

Conditions
Carbapenem-Resistant Enterobacteriaceae InfectionPneumonia - Bacterial
Interventions
DEVICE

Polymyxin B Sulfate 25mg Jet Nebulization / Vibrating Mesh Nebulization

"* Group A: 25mg polymyxin B sulfate dissolved in 5ml sterile water, administered via jet nebulizer under mechanical ventilation.~* Group B: 25mg polymyxin B sulfate dissolved in 5ml sterile water, administered via vibrating mesh nebulizer under mechanical ventilation."

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER